Hamilton Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-245
Closed -$225K 37
2026
Q1
$225K Buy
+245
New +$248K 0.07% 27
2025
Q2
Sell
-601
Closed -$496K 28
2025
Q1
$496K Sell
601
-6,104
-91% -$5.08M 0.31% 17
2024
Q4
$5.18M Buy
+6,705
New +$5.55M 3.23% 13

Other funds holding LLY

Hamilton Capital Partners's LLY Position: Q2 2026 in Review

Hamilton Capital Partners sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 245 shares — an estimated $225K sold.

Hamilton Capital Partners first reported a position in LLY in Q4 2024 and held it in 3 quarters. The position peaked at $5.18M in Q4 2024. 2,501 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hamilton Capital Partners reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Hamilton Capital Partners sold 245 Eli Lilly shares in Q2 2026, an estimated $225K.
  • Hamilton Capital Partners first reported a position in Eli Lilly in Q4 2024 and held it in 3 quarters.
  • Hamilton Capital Partners's Eli Lilly position peaked at $5.18M in Q4 2024.
  • 2,501 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hamilton Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.